The cure from within? a review of the microbiome and diet in melanoma

Siegel, R. L., et al. (2021). Cancer Statistics, 2021. CA: A cancer journal for clinicians., 71(1), 7–33.

Google Scholar 

Berk-Krauss, J., et al. (2020). New systematic therapies and trends in cutaneous melanoma deaths among US Whites, 1986–2016. American Journal of Public Health, 110(5), 731–733.

PubMed  Article  Google Scholar 

Siegel, R.L., et al., Cancer statistics, 2022. CA: A Cancer Journal for Clinicians. n/a(n/a).

Grob, J. J., et al. (1998). Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases French Cooperative Group on Melanoma. Lancet, 351(9120), 1905–10.

CAS  PubMed  Article  Google Scholar 

Davar, D., et al. (2017). High-dose interleukin-2 (HD IL-2) for advanced melanoma: A single center experience from the University of Pittsburgh Cancer Institute. Journal for ImmunoTherapy of Cancer, 5(1), 74.

PubMed  PubMed Central  Article  Google Scholar 

Hodi, F. S., et al. (2010). Improved survival with ipilimumab in patients with metastatic melanoma. New England Journal of Medicine, 363(8), 711–723.

CAS  Article  Google Scholar 

Robert, C., et al. (2011). Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. New England Journal of Medicine, 364(26), 2517–2526.

CAS  Article  Google Scholar 

Larkin, J., et al. (2019). Five-year survival with combined nivolumab and ipilimumab in advanced melanoma. New England Journal of Medicine, 381(16), 1535–1546.

CAS  Article  Google Scholar 

Robert, C., et al. (2015). Nivolumab in previously untreated melanoma without BRAF mutation. New England Journal of Medicine, 372(4), 320–330.

CAS  Article  Google Scholar 

Weber, J. S., et al. (2015). Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): A randomised, controlled, open-label, phase 3 trial. The lancet Oncology, 16(4), 375–384.

CAS  PubMed  Article  Google Scholar 

Lipson, E. J., et al. (2021). Relatlimab (RELA) plus nivolumab (NIVO) versus NIVO in first-line advanced melanoma: Primary phase III results from RELATIVITY-047 (CA224–047). Journal of Clinical Oncology., 39(15_suppl), 9503–9503.

Article  Google Scholar 

Yap, T. A., et al. (2021). Development of immunotherapy combination strategies in cancer. Cancer Discovery, 11(6), 1368–1397.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Tawbi, H. A., et al. (2022). Relatlimab and nivolumab versus nivolumab in untreated advanced melanoma. New England Journal of Medicine, 386(1), 24–34.

CAS  Article  Google Scholar 

Yatsunenko, T., et al. (2012). Human gut microbiome viewed across age and geography. Nature, 486(7402), 222–227.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Grice, E. A. (2015). The intersection of microbiome and host at the skin interface: Genomic- and metagenomic-based insights. Genome Research, 25(10), 1514–1520.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Belkaid, Y., & Segre, J. A. (2014). Dialogue between skin microbiota and immunity. Science, 346(6212), 954–959.

CAS  PubMed  Article  Google Scholar 

Byrd, A. L., Belkaid, Y., & Segre, J. A. (2018). The human skin microbiome. Nature Reviews Microbiology, 16(3), 143–155.

CAS  PubMed  Article  Google Scholar 

Schadendorf, D., et al. (2018). Melanoma. The Lancet, 392(10151), 971–984.

Article  Google Scholar 

Feng, H., et al. (2008). Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science, 319(5866), 1096–1100.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Berman, T. A., & Schiller, J. T. (2017). Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases. Cancer, 123(12), 2219–2229.

PubMed  Article  Google Scholar 

Bazaliński, D., et al. (2017). Marjolin’s ulcer in chronic wounds - review of available literature. Contemp Oncol (Pozn), 21(3), 197–202.

Google Scholar 

Salava, A., et al. (2016). Skin microbiome in melanomas and melanocytic nevi. European Journal of Dermatology, 26(1), 49–55.

CAS  PubMed  Article  Google Scholar 

Mizuhashi, S., et al. (2021). Skin microbiome in acral melanoma: Corynebacterium is associated with advanced melanoma. The Journal of Dermatology, 48(1), e15–e16.

PubMed  Article  Google Scholar 

Laihia, J. K., et al. (2010). Protodynamic intracellular acidification by cis-urocanic acid promotes apoptosis of melanoma cells in vitro and in vivo. Journal of Investigative Dermatology, 130(10), 2431–2439.

CAS  Article  Google Scholar 

Naik, S., et al. (2012). Compartmentalized control of skin immunity by resident commensals. Science, 337(6098), 1115–1119.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Vitiello, G.A. and G. Miller (2020) Targeting the interleukin-17 immune axis for cancer immunotherapy. Journal of Experimental Medicine, 217(1).

Nakatsuji, T., et al. (2018). A commensal strain of Staphylococcus epidermidis protects against skin neoplasia. Science Advances., 4(2), eaao4502.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Raja, J., et al. (2018). Oncolytic virus immunotherapy: Future prospects for oncology. Journal for ImmunoTherapy of Cancer, 6(1), 140.

PubMed  PubMed Central  Article  Google Scholar 

Andtbacka, R. H., et al. (2015). Talimogene laherparepvec improves durable response rate in patients with advanced melanoma. Journal of Clinical Oncology, 33(25), 2780–2788.

CAS  PubMed  Article  Google Scholar 

Camara, N.O.S. (2021). Do the gut and skin microbiomes share thoughts on melanoma development? British Journal of Dermatology.

Almeida, A., et al. (2019). A new genomic blueprint of the human gut microbiota. Nature, 568(7753), 499–504.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Sender, R., Fuchs, S., & Milo, R. (2016). Revised estimates for the number of human and bacteria cells in the body. PLoS Biol, 14(8), e1002533.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Li, W., et al. (2019). Gut microbiome and cancer immunotherapy. Cancer Letters, 447, 41–47.

CAS  PubMed  Article  Google Scholar 

Louis, P., Hold, G. L., & Flint, H. J. (2014). The gut microbiota, bacterial metabolites and colorectal cancer. Nature Reviews Microbiology, 12(10), 661–672.

CAS  PubMed  Article  Google Scholar 

Belkaid, Y., & Hand, T. W. (2014). Role of the microbiota in immunity and inflammation. Cell, 157(1), 121–141.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Hall, J. A., et al. (2008). Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity, 29(4), 637–649.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wu, H. J., & Wu, E. (2012). The role of gut microbiota in immune homeostasis and autoimmunity. Gut Microbes, 3(1), 4–14.

PubMed  PubMed Central  Article  Google Scholar 

Zhou, C. B., Zhou, Y. L., & Fang, J. Y. (2021). Gut microbiota in cancer immune response and immunotherapy. Trends Cancer, 7(7), 647–660.

CAS  PubMed  Article  Google Scholar 

Sivan, A., et al. (2015). Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science, 350(6264), 1084–1089.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Bessell, C.A., et al. (2020). Commensal bacteria stimulate antitumor responses via T cell cross-reactivity. JCI Insight, 5(8).

Fluckiger, A., et al. (2020). Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage. Science, 369(6506), 936–942.

CAS  PubMed  Article  Google Scholar 

Vétizou, M., et al. (2015). Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science, 350(6264), 1079–1084.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Matson, V., et al. (2018). The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science, 359(6371), 104–108.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Gopalakrishnan, V., et al. (2018). Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science, 359(6371), 97–103.

CAS  PubMed  Article  Google Scholar 

Wang, S., et al. (2016). Systematic review: Adverse events of fecal microbiota transplantation. PLoS One, 11(8), e0161174.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Tanoue, T., et al. (2019). A defined commensal consortium elicits CD8 T cells and anti-cancer immunity. Nature, 565(7741), 600–605.

CAS  PubMed  Article  Google Scholar 

Mager, L. F., et al. (2020). Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy. Science, 369(6510), 1481–1489.

留言 (0)

沒有登入
gif